Treatment-adjusted prevalence to assess HIV testing programmes
Beth Tippett Barr(Centers for Disease Control and Prevention), Andreas Jahn(University of Washington), John H. Rogers(Centers for Disease Control and Prevention), David Lowrance(World Health Organization), Rachel Baggaley(World Health Organization), Marc Bulterys(Centers for Disease Control and Prevention), Shirish Balachandra(Centers for Disease Control and Prevention), Sudhir Bunga(Centers for Disease Control and Prevention), Thokozani Kalua(Ministry of Health), Danielle Payne(Centers for Disease Control and Prevention), Joseph Barker(Centers for Disease Control and Prevention), Daniel Low‐Beer(World Health Organization)
Cited by 8
Related Papers
WNT1-inducible signaling protein–1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis
|Journal of Clinical Investigation|2009|556
Requirements for global elimination of hepatitis B: a modelling study
|The Lancet Infectious Diseases|2016|384
Global reporting of progress towards elimination of hepatitis B and hepatitis C
|The Lancet. Gastroenterology & hepatology|2023|323